Winton Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-10,882
| Closed | -$989K | – | 1189 |
|
|
2023
Q1 | $989K | Buy |
10,882
+1,865
| +21% | +$170K | 0.06% | 449 |
|
|
2022
Q4 | $343K | Buy |
9,017
+331
| +4% | +$12.6K | 0.02% | 754 |
|
|
2022
Q3 | $218K | Sell |
8,686
-1,132
| -12% | -$28.4K | 0.01% | 863 |
|
|
2022
Q2 | $298K | Sell |
9,818
-6,510
| -40% | -$198K | 0.02% | 805 |
|
|
2022
Q1 | $535K | Buy |
+16,328
| New | +$535K | 0.03% | 662 |
|
|
2021
Q3 | – | Sell |
-2,733
| Closed | -$387K | – | 1513 |
|
|
2021
Q2 | $387K | Sell |
2,733
-2,404
| -47% | -$340K | 0.02% | 1057 |
|
|
2021
Q1 | $512K | Buy |
5,137
+742
| +17% | +$74K | 0.03% | 876 |
|
|
2020
Q4 | $543K | Sell |
4,395
-8,526
| -66% | -$1.05M | 0.04% | 752 |
|
|
2020
Q3 | $1.26M | Buy |
+12,921
| New | +$1.26M | 0.04% | 714 |
|
|
2019
Q2 | – | Sell |
-2,386
| Closed | -$204K | – | 1319 |
|
|
2019
Q1 | $204K | Buy |
+2,386
| New | +$204K | ﹤0.01% | 964 |
|